Legal Archives - Boston Life Sciences Times

Amylyx Reports Positive Phase 3 Results for Avexitide in Post-Bariatric Hypoglycemia

August 18, 2026

Zai Lab, argenx Report Positive Phase 3 Results for Efgartigimod in Autoimmune Myositis

August 17, 2026

FDA Approves Lantheus’ TAUKLARIFY for Alzheimer’s Disease Evaluation

August 14, 2026

THIS WEEK'S STORIES

Juvena Therapeutics Names Julie Anne Smith CEO as JUV-161 Advances in Phase 2

August 17, 2026

WHOOP Expands Advanced Labs Access, Adds GRAIL’s Galleri Cancer Detection Test

August 18, 2026

eClinicalWorks, healow Help Maine Health Center Expand Patient Access

August 13, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Legal

Insulet Faces Securities Lawsuit Over Omnipod Manufacturing Disclosures

Federal Court Bans 19 Sellers of Fake Urolithin A Supplements, Awards Timeline $5.3 Million

NeoGenomics Reaches $9.8 Million Settlement Over Laboratory Consulting Program

PODD Investors Alerted to Securities Class Action Against Insulet

Investors Face May 4 Deadline in Lawsuit Over Boston Scientific Stock Drop

Most Read

Abcuro Raises $66 Million to Advance Ulviprubart in Inclusion Body Myositis

Azara Healthcare Names Ashley Basile Chief Strategy Officer, Josh Taylor Chief Revenue Officer

Ingenia Therapeutics Begins Trading on KOSDAQ to Advance Vascular Antibody Pipeline

Ora Appoints John Trein as Therapeutic Lead for Posterior Segment Programs

EDITOR PICKS